Indaptus Therapeutics Inc. said shareholders approved a proposal authorizing its board to implement up to two reverse stock splits of the company’s common stock, with an aggregate split ratio ranging from 1-for-2 to 1-for-199. The final ratio and timing will be determined by the board and carried out through an amendment to the company’s certificate of incorporation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-008326), on February 27, 2026, and is solely responsible for the information contained therein.